Portside Wealth Group »

Alnylam Pharmaceuticals shares owned by Portside Wealth Group

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Portside Wealth Group from 13F filings

Historical chart of Portside Wealth Group investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Portside Wealth Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Portside Wealth Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $343k 751 456.00

More positions owned by Portside Wealth Group

Spdr Series Trust Bloomberg 1-3 Mo (BIL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Spdr Series Trust Prtflo S&p500 Gw (SPYG)
Oracle Corporation (ORCL)
Amazon (AMZN)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Spdr Series Trust Prtflo S&p500 Vl (SPYV)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Visa Com Cl A (V)
Spdr Index Shs Fds Portfolio Emg Mk (SPEM)
Apple (AAPL)
Netflix (NFLX)
Shopify Cl A Sub Vtg Shs (SHOP)
Meta Platforms Cl A (META)

View all positions for Portside Wealth Group

Top funds holding Alnylam Pharmaceuticals

FMR
Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
Jpmorgan Chase & Co
Groupama Asset Managment
State Street Corporation
Baillie Gifford & Co
Geode Capital Management
Dodge & Cox
T. Rowe Price Investment Management
Orbis Allan Gray
Wellington Management Company
Susquehanna International

View all funds holding Alnylam Pharmaceuticals